Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2023 10:20 ET | Source: Psycheceutical Bioscience, Inc.

Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD

MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. (OTCPK: BWVI) ("Psycheceutical" or the "Company"), a bioscience company dedicated to developing cutting-edge brain delivery...
January 26, 2023 12:15 ET | Source: Psycheceutical Bioscience, Inc.

Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD

MIAMI, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge treatments for...
January 10, 2023 14:05 ET | Source: Psycheceutical Bioscience, Inc.

Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer

MIAMI, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc.(OTCPK: BWVI) ("Psycheceutical" or the "Company"), a bioscience company dedicated to developing cutting-edge brain delivery...
November 29, 2022 11:35 ET | Source: Psycheceutical Bioscience, Inc.

Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director

MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
October 18, 2022 10:15 ET | Source: Psycheceutical Bioscience, Inc.

Psycheceutical Bioscience, Inc. Announces Medical Advisory Board

MIAMI, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
September 13, 2022 11:15 ET | Source: Psycheceutical Bioscience, Inc.

Psycheceutical Bioscience, Inc.'s CEO to Present at the Life Sciences Investor Forum on September 15

MIAMI, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
August 16, 2022 10:14 ET | Source: Psycheceutical Bioscience, Inc.

Psycheceutical Bioscience, Inc. Enters into Exclusive Option to Acquire Vici Health Sciences

MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. (“Psycheceutical” or the “Company”) (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...